Trial intelligence / Profile preview

The Effect of L-arginine on Brown Adipose Tissue Metabolism in South Asian and White Caucasian Subjects

NCT02291458Phase 3Unknown

Sponsor
Maastricht University Medical Center+
Start
Nov 2014
Primary completion
Oct 2015
Modality
Peptides, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of arginine in glucose intolerance and obesity (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Standard uptake value of Brown adipose tissue at 6 weeks, Energy expenditure at 6 weeks and 1 more. Status: unknown.

02

Drugs

arginine
03

Conditions

glucose intoleranceobesity

Beyond the preview

Go deeper on NCT02291458.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02291458.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call